Zobrazeno 1 - 10
of 63
pro vyhledávání: '"R E Ramsay"'
Autor:
R. E. Ramsay, D. Ko
Publikováno v:
Acta Neurologica Scandinavica. 127:36-43
To evaluate the efficacy of adjunctive, once-daily perampanel against secondarily generalized (SG) seizures in three Phase III trials (studies 304, 305, and 306) and their extension (study 307). The Phase III studies enrolled patients (≥ 12 years)
Autor:
M. Jane Riddoch, Jill R. E. Ramsay
Objectives: To investigate the accuracy in position-matching in the upper limb in two groups of subjects who were physically fit and movement aware. Design: A mixed-group design was used. Objective measurement of the accuracy in position-matching at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0abed074eacf6e23abbe90fe21c92427
https://doi.org/10.1191/026921501666288152
https://doi.org/10.1191/026921501666288152
Autor:
Susan E. Marino, Jae Eun Ahn, John O. Rarick, Ilo E. Leppik, James C. Cloyd, L. C. Musib, Angela K. Birnbaum, R. E. Ramsay, James R. White, Richard C. Brundage, Jeannine M. Conway
Publikováno v:
Neurology. 71:38-43
Background: Phenytoin (PHT) is widely used to treat epilepsy in elderly patients, but information on its pharmacokinetics in this population is limited. Objective: The purpose of this study was to investigate the effects of age and sex on PHT pharmac
Autor:
Richard H. Mattson, R. E. Ramsay, Frank Gilliam, Alan R. Towne, Thaddeus S. Walczak, James C. Cloyd, W. A. Hauser
Publikováno v:
Epilepsy Research. 68:39-48
Both the incidence and prevalence of epilepsy are high among the elderly. Cerebrovascular disease is the most common underlying cause, although as many as 25-40% of new epilepsy cases in the elderly have no obvious underlying etiology. Status epilept
Autor:
Flavia Pryor, Mark C. Spitz, J. Felicetta, K. D. Boardman, Basim M. Uthman, R. E. Ramsay, W. Marks, Joseph F. Collins, A. Towne, M. L. Tomyanovich, T. Frederick, Gregory S. Carter, A. J. Rowan
Publikováno v:
Neurology. 64:1868-1873
Objective: To determine the relative tolerability and efficacy of two newer antiepileptic drugs, lamotrigine (LTG) and gabapentin (GBP), as compared to carbamazepine (CBZ) in older patients with epilepsy. Methods: This was an 18-center, randomized, d
Autor:
D Cantrell, R. E. Ramsay, Stephen D. Collins, James C. Cloyd, Kenneth W. Sommerville, Dean K. Naritoku, J.K Walch
Publikováno v:
Epilepsy Research. 52:189-201
Background: Valproate sodium injection (Depacon®) is an intravenous form of valproate for use in absence and complex partial seizures when circumstances preclude oral administration. Certain situations may warrant larger and more rapid infusions tha
Autor:
P. D. Meyers, M B Mamdani, C Colling, Joseph F. Collins, V P Calabrese, David M. Treiman, N. Y. Walton, Adrian Handforth, Basim M. Uthman, Edward Faught, A. J. Rowan, R. E. Ramsay
Publikováno v:
New England Journal of Medicine. 339:792-798
Background and Methods Although generalized convulsive status epilepticus is a life-threatening emergency, the best initial drug treatment is uncertain. We conducted a five-year randomized, double-blind, multicenter trial of four intravenous regimens
Autor:
Cynthia L. Harden, B. Abou-Khalil, James Chris Sackellares, A. Hayes, Ahmad Beydoun, D. Cantrell, James H. Fischer, R. E. Ramsay, M.W. Pierce, Martha Greiner, Douglas Labar, E. A. Garofalo, Basim M. Uthman
Publikováno v:
Neurology. 49:746-752
This study evaluated gabapentin monotherapy in 275 patients with medically refractory complex partial or secondarily generalized seizures who were taking one or two antiepileptic drugs (AEDs). Following an 8-week baseline, patients received randomize
Publikováno v:
Neurology. 46:1684-1690
We conducted a randomized double-blind comparison of three doses of the novel antiepileptic drug (AED) topiramate (200, 400, and 600 mg/day) and placebo as adjunctive therapy in patients with refractory partial onset epilepsy receiving one or two oth
Publikováno v:
Annals of Neurology. 38:670-674
This multicenter, open-label trial was designed to study the safety of intravenous (IV) sodium valproate in patients with epilepsy. All 318 patients (previously treated with antiepileptic drugs) were hospitalized for seizure control or anticipated se